Abiopharma

🔍 MOTL CHRISTOPHER J (Executive)

Company: WEBSTER FINANCIAL CORP (WBS)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Acquired 41,307 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 126,746.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 16,256 shares of Common Stock at $79.07 per share (Direct)
  Date: 2026-08-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 110,490.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 2,244 shares of Common Stock at $79.07 per share (Direct)
  Date: 2026-08-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 108,246.00 | transaction_form_type: 4 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: H | nature_of_ownership: 401(k) plan | shares_owned_after: 8,859.92

Footnotes:

• F1: Represents the vesting of certain performance shares that were accelerated pursuant to the Transaction Agreement, dated as of February 3, 2026, by and among Webster Financial Corporation, Banco Santander, S.A. and Webster Virginia Corporation.
• F2: Represents the tax withholding upon the vesting of certain performance shares that were accelerated pursuant to the Transaction Agreement, dated as of February 3, 2026, by and among Webster Financial Corporation, Banco Santander, S.A. and Webster Virginia Corporation.
• F3: Represents the tax withholding upon the vesting of certain time-based restricted shares that were accelerated pursuant to the Transaction Agreement, dated as of February 3, 2026, by and among Webster Financial Corporation, Banco Santander, S.A. and Webster Virginia Corporation.